Atazanavir atazanavir is a structural analog of the transition state during which the bond between a phenylalanine and proline is broken. Humans do not have any enzymes that break bonds between phenylalanine and proline, so this drug will not target human enzymes. Atazanavir is available as a 150 mg capsule, 200 mg capsule, 300 mg capsule, and 50 mg oral powder packet. The 300 mg capsule should reduce pill burden, as one 300 mg capsule may replace two 150 mg capsules. Atazanavir Atazanavir, sold under the trade name Reyataz among others, is an antiretroviral medication used to treat and prevent HIV/AIDS.
Center for Drug and Alcohol Programs is Raymond Anton, M.D. He is an addiction psychiatrist and psychopharmacologist, as well as a professor of psychiatry and behavioral science at MUSC. Center for Drug and Alcohol Programs The Center for Drug and Alcohol Programs (CDAP) at Medical University of South Carolina (MUSC) is located in Charleston. The center provides treatment and research for drug, alcohol and substance addiction. It is one of only 14 National Institutes of Health (NIH) funded Alcohol Research Centers in the United States. In 2012, the Center for Drug and Alcohol Programs, through its affiliation with MUSC’s College of Medicine, ranked as one of